glp 1 rhabdomyolysis Frontiers Glucagon-like peptide and its receptor

Victoza is a GLP-1 medication approved by the FDA to treat type 2 diabetes and is also prescribed off-label for weight loss

We delineate how systemic metabolic dysfunction, often associated with obesity, synergizes with local inflammation to alter the balance between MMPs and their tissue inhibitors TIMPs, thus contributing to a perpetuating circle of inflammation and fibrosis

Get practical tips and insights to enhance your journey

Conclusions While GLP-1 receptor agonists do not appear to significantly increase overall surgical risks, their effects on tissue healing and bruising warrant further investigation

Discover if there are any GLP-1 medications in pill form